Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study

The Lancet HIV

Volumn 4, Issue 2, 2017, Pages e67-e73

  Sigel, Keith ^a   Wisnivesky, Juan ^a   Crothers, Kristina ^b   Gordon, Kirsha ^c   Brown, Sheldon T ^a,d   Rimland, David ^e   Rodriguez Barradas, Maria C ^f   Gibert, Cynthia ^g   Goetz, Matthew Bidwell ^h,i   Bedimo, Roger ^j   Park, Lesley S ^k   Dubrow, Robert ^l  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^h VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l YALE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ALCOHOLISM; ARTICLE; CANCER REGISTRY; CANCER RISK; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG ABUSE; ETHNICITY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; OCCUPATIONAL LUNG DISEASE; PNEUMONIA; PRIORITY JOURNAL; SMOKING; UNITED STATES; VETERAN; BLOOD; COMPLICATION; IMMUNOLOGY; INFLAMMATION; LUNG NEOPLASMS; PNEUMONIA, BACTERIAL; PREVALENCE; RISK FACTOR; VIROLOGY;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HIV INFECTIONS; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PREVALENCE; RISK FACTORS; RNA, VIRAL; SMOKING; UNITED STATES; VETERANS;

EID: 85007499786     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(16)30215-6     Document Type: Article

References (30)

1. 1 Engels, EA, Pfeiffer, RM, Goedert, JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 20 (2006), 1645–1654.
2. 2 Simard, EP, Engels, EA, Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis 51 (2010), 957–962.
3. 3 Shiels, MS, Pfeiffer, RM, Gail, MH, et al. Cancer burden in the HIV-infected population in the United States. JNCI 103 (2011), 753–762.
4. 4 Sigel, K, Wisnivesky, J, Gordon, K, et al. HIV as an independent risk factor for incident lung cancer. AIDS 26 (2012), 1017–1025.
5. 5 Silverberg, MJ, Chao, C, Leyden, WA, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 20 (2011), 2551–2559.
6. 6 Shebl, FM, Engels, EA, Goedert, JJ, Chaturvedi, AK, Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr 55 (2010), 375–379.
7. 7 Guiguet, M, Boué, F, Cadranel, J, Lang, J-M, Rosenthal, E, Costagliola, D, Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 10 (2009), 1152–1159.
8. 8 Engels, EA, Brock, MV, Chen, J, Hooker, CM, Gillison, M, Moore, RD, Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 24 (2006), 1383–1388.
9. 9 Clifford, GM, Lise, M, Franceschi, S, et al. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer 106 (2012), 447–452.
10. 10 Benard, A, Mercie, P, Alioum, A, et al. Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000–2007. PloS One, 5, 2010, e8896.
11. 11 Brenner, DR, McLaughlin, JR, Hung, RJ, Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PloS One, 6, 2011, e17479.
12. 12 Strindhall, J, Skog, M, Ernerudh, J, et al. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age 35 (2013), 985–991.
13. 13 Serrano-Villar, S, Sainz, T, Lee, SA, et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathogens, 10, 2014, e1004078.
14. 14 Serrano-Villar, S, Perez-Elias, MJ, Dronda, F, et al. Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio. PloS One, 9, 2014, e85798.
15. 15 Park, LS, Tate, JP, Rodriguez-Barradas, MC, et al. Cancer incidence in HIV-infected versus uninfected veterans: comparison of cancer registry and ICD-9 code diagnoses. J AIDS Clin Res, 5, 2014, 1000318.
16. 16 Losina, E, Yazdanpanah, Y, Deuffic-Burban, S, et al. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Cote d'Ivoire. Antivir Ther 12 (2007), 543–551.
17. 17 Helleberg, M, Kronborg, G, Larsen, CS, et al. CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV. Clin Infect Dis 57 (2013), 314–321.
18. 18 Bradburn, MJ, Clark, TG, Love, SB, Altman, DG, Survival analysis Part III: multivariate data analysis — choosing a model and assessing its adequacy and fit. Br J Cancer 89 (2003), 605–611.
19. 19 Remark, R, Becker, C, Gomez, JE, et al. The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. Am J Respir Crit Care Med 191 (2015), 377–390.
20. 20 Borghaei, H, Paz-Ares, L, Horn, L, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 373 (2015), 1627–1639.
21. 21 Kesselring, A, Gras, L, Smit, C, et al. Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clin Infect Dis 52 (2011), 1458–1465.
22. 22 Hleyhel, M, Cancer Risk Group of the French Hospital Database on HIV. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort. AIDS 28 (2014), 2109–2118.
23. 23 Helleberg, M, Kronborg, G, Ullum, H, Ryder, LP, Obel, N, Gerstoft, J, Course and clinical significance of CD8+ T-cell counts in a large cohort of HIV-infected individuals. J Infect Dis 211 (2015), 1726–1734.
24. 24 Buggert, M, Frederiksen, J, Noyan, K, et al. Multiparametric bioinformatics distinguish the CD4/CD8 ratio as a suitable laboratory predictor of combined T cell pathogenesis in HIV infection. J Immunol 192 (2014), 2099–2108.
25. 25 Rubbo, PA, Tuaillon, E, Bollore, K, et al. The potential impact of CD4+ T cell activation and enhanced Th1/Th2 cytokine ratio on HIV-1 secretion in the lungs of individuals with advanced AIDS and active pulmonary infection. Clin Immunol 139 (2011), 142–154.
26. 26 Makinson, A, Le Moing, V, Reynes, J, et al. Lung cancer screening with chest computed tomography in people living with HIV. A review by the multidisciplinary CANCERVIH Working Group. J Thorac Oncol 11 (2016), 1644–1652.
27. 27 Wu, D, Erwin, D, Rosner, GL, Sojourn time and lead time projection in lung cancer screening. Lung Cancer 72 (2011), 322–326.
28. 28 Kabali, C, Cheng, DM, Brooks, DR, Bridden, C, Horsburgh, CR Jr, Samet, JH, Recent cigarette smoking and HIV disease progression: no evidence of an association. AIDS Care 23 (2011), 947–956.
29. 29 Craib, KJ, Schechter, MT, Montaner, JS, et al. The effect of cigarette smoking on lymphocyte subsets and progression to AIDS in a cohort of homosexual men. Clin Invest Med 15 (1992), 301–308.
30. 30 Tollerud, DJ, Clark, JW, Brown, LM, et al. The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. Am Rev Respir Dis 139 (1989), 1446–1451.